Results 91 to 100 of about 2,813 (193)

Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis

open access: yesThe Cancer Journal, 2020
Abstract Oligometastasis represents an intermediate disease stage between localized and widely metastatic cancer. Efficient identification of patients with oligometastasis remains a barrier for accrual on clinical trials of oligometastasis-directed therapy.
David M, Routman   +2 more
openaire   +3 more sources

Quality of Life of Oligometastatic and Polymetastatic Head and Neck Squamous Cell Carcinoma Patients [PDF]

open access: yes
Objective: Evidence suggests that distant metastasis in head and neck squamous cell carcinoma is a spectrum of disease. Previous studies show that oligometastasis has favorable survival compared with polymetastasis.
Berzenji, Diako   +6 more
core   +1 more source

Oligometastasis: More Lessons to Be Learned

open access: yesCancer Research and Treatment, 2023
Kim, Kyung Hwan, Ahn, Yong Chan
openaire   +2 more sources

Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)

open access: yes, 2021
Background According to current guidelines, treatment of patients with hepatic oligometastasis in pancreatic cancer is not reflected and systemic chemotherapy is recommended in those patients.
Christiane Bruns   +21 more
core   +1 more source

Case Report: Endoscopic submucosal dissection revealed isolated gastric metastasis from primary bladder urothelial carcinoma: clinicopathological analysis and literature review

open access: yesFrontiers in Medicine
A 73-year-old male was admitted to our department with complaints of upper abdominal distension, accompanied by dull pain and belching for more than 10 days.
Famei Xu   +6 more
doaj   +1 more source

Local ablative radiotherapy for oligometastatic non-small cell lung cancer [PDF]

open access: yes, 2019
In metastatic non-small cell lung cancer (NSCLC), the role of radiotherapy (RT) has been limited to palliation to alleviate the symptoms. However, with the development of advanced RT techniques, recent advances in immuno-oncology therapy targeting ...
조재호, Jaeho Cho, Yang-Gun Suh
core   +1 more source

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease

open access: yesOncoImmunology
Stereotactic ablative radiotherapy (SABR) may extend the clinical benefit of immune checkpoint inhibitors (ICI) in patients with oligoprogressive disease. However, individual benefit varies, and validated biomarkers to guide patient selection are lacking.
Juan Zafra-Martin   +14 more
doaj   +1 more source

Surgery for oligometastasis of pancreatic cancer.

open access: yesChinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2015
The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable ...
Fengchun, Lu   +2 more
openaire   +1 more source

Case Report: Exceptional long-term survival in metastatic pancreatic ductal adenocarcinoma after repeated high-dose hypofractionated lesion-directed radiotherapy

open access: yesFrontiers in Oncology
Metastatic pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, and survival beyond a decade is exceptional. We report a 59-year-old man with stage IV PDAC presenting with oligometastatic disease involving a pancreatic head/uncinate primary ...
Mingli Ding   +5 more
doaj   +1 more source

Ultrasound-guided microwave ablation for metastatic breast cancer: a 3-year follow-up case report and review of the literature

open access: yesFrontiers in Oncology
This case describes the application of ultrasound-guided microwave ablation (MWA) in the management of a solitary breast metastatic lesion in a 59-year-old female with a history of lung adenocarcinoma.
Juan Li   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy